WHO
© Credits

Tuberculosis

    Overview

    Tuberculosis (TB) is a contagious airborne disease caused mainly by Mycobacterium tuberculosis. It most often affects the lungs and it spreads through the air when people with pulmonary TB cough, sneeze or spit. A person only needs to inhale a few germs to become infected.

    Socioeconomic factors like poverty, inequality, food insecurity and inadequate living and working conditions can increase the likelihood of an infected person developing TB, exacerbate the risk of disease progression and hinder effective treatment. Those with compromised immune systems, such as people living with HIV, malnutrition, diabetes or people with substance use disorders, have a higher risk of falling ill with TB. With timely diagnosis and appropriate treatment, further spread of the disease can be prevented.

    Impact

    In the WHO European Region, over 170 000 new episodes of TB were reported in 2023. While the Region accounts for only 2.1% of the global TB burden, it bears a significant share of drug-resistant TB (DR-TB), with 21% of global multidrug-resistant TB (MDR-TB) cases and 37% of pre-extensively DR-TB cases. Despite the fastest global decline in TB deaths (38% reduction), the Region remains off track to achieve the 75% reduction target by 2025.

    WHO response

    The WHO Regional Office for Europe leads the fight against TB in the Region by focusing on:

    1. prevention and systematic screening
    2. early diagnosis
    3. improved treatment, particularly for DR-TB.

    Accelerating progress towards TB elimination

    WHO aims to accelerate progress towards TB elimination by helping countries to:

    1. strengthen their health systems;
    2. ensure that everyone has access to quality integrated people-centred care, leaving no one behind;
    3. focus on helping groups of people most at risk; and
    4. bring different parts of society together to fight TB.

    However, challenges such as declining international funding and geopolitical instability threaten these efforts, making stronger national commitments and multisectoral collaborative and coordinated actions more critical than ever.

    Plan for action

    Current TB response efforts in the Region are guided by the Tuberculosis action plan for the WHO European Region 2023–2030 – the main strategic and guiding regional-level document for accelerated actions to end TB. The plan, along with its monitoring and evaluation framework , outlines the vision and strategic actions for the regional TB response. It has been crucial in aligning national strategies with WHO guidelines and policies.

    At the global level, WHO supports the implementation of the End TB Strategy, which outlines the vision, goal, targets and milestones for eliminating TB and includes key indicators to measure progress. WHO works closely with key international and national partners and civil society organizations to help Member States to implement the strategy and eliminate TB.

    Our work

    All →
    Protecting human rights, ethics and equity for tuberculosis patients

    Protecting human rights, ethics and equity for tuberculosis patients

    WHO/Malin Bring
    © Credits

    Overview

    “Protecting human rights, ethics and equity” is one of the 4 key principles of the WHO End TB Strategy. This is especially relevant for tuberculosis (TB), which is widespread among the most vulnerable and marginalized populations. This approach is fully aligned with the 2030 Agenda for Sustainable Development and its focus on human rights, ethics and equity, which is summarized in the motto “leave no one behind”.

    Stigma linked to TB (infectiousness, long treatment, possible HIV co-infection) and the social conditions that are often related to it (poverty, imprisonment, migration, etc.) are important causes of lower access to services and further social discrimination. In the WHO European Region, the high levels of multidrug-resistant TB (MDR-TB) make the protection of ethics, values, and human rights a special challenge, particularly in relation to:

    • diagnosis (in the absence of effective treatment);
    • treatment (isolation and involuntary treatment of patients; support for patients’ adherence; compassionate use and expanded access to TB drugs; palliative and end-of-life care; research; health workers’ rights and responsibilities); and
    • interventions within specific groups (children, prisoners, migrants).

    Human rights are mainly concerned with the relationship between the individual and the state, but also include responsibilities for private, non-state actors. Governmental obligations with regard to human rights broadly fall under the principles of respect, protect and fulfil. The right to health – articulated as the highest attainable standard of physical and mental health – is enshrined in the WHO Constitution, the Universal Declaration of Human Rights (Article 25) and the International Covenant on Economic, Social and Cultural Rights (Article 12).

    WHO/Europe assists Member States in protecting and promoting human rights, ethics and equity for TB patients by reviewing current legislation and practices and advising for their alignment with ethics and human rights principles.

    Publications

    All →
    TB-Free Central Asia Initiative

    The TB-Free Central Asia Initiative is a regional effort led by the WHO Regional Office for Europe aimed at eliminating tuberculosis (‎TB)‎ and...

    Tuberculosis surveillance and monitoring in Europe 2025 – 2023 data

    This report has been published jointly by the European Centre for Disease Prevention and Control (‎ECDC)‎ and the World Health Organization (‎WHO)‎...

    Related WHO collaborating centres

    WHO collaborating centres are institutions that form an international collaborative network carrying out activities to support WHO’s programmes at all levels. They provide an opportunity for WHO to utilize their inherent expertise for the benefit of all Member States.

    View the list of related collaborating centres